These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38905369)

  • 1. Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view.
    Ma Y; Sheng J; Wang L; Zhang Y; Liu L
    Medicine (Baltimore); 2024 Jun; 103(25):e38350. PubMed ID: 38905369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature.
    Ying YQ; Hou L; Liang Y; Wu W; Luo XP
    Growth Horm IGF Res; 2018; 42-43():80-85. PubMed ID: 30343148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency.
    Gou P; Cheng X; Leng J; Su N
    Ther Clin Risk Manag; 2022; 18():113-124. PubMed ID: 35342293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different therapy regimens to increase final adult height in males at advanced bone age with idiopathic short stature.
    Wang W; Wang Y; Xiao Y; Cao N; Wang Y
    BMC Pediatr; 2023 Dec; 23(1):615. PubMed ID: 38053091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study.
    Xie L; Li Y; Zhang J; Guo S; Chen Q; Ma H; Jiang W
    Eur J Pediatr; 2024 Oct; 183(10):4531-4539. PubMed ID: 39158594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMI z-score as a prognostic factor for height velocity in children treated with recombinant human growth hormone due to idiopathic growth hormone deficiency.
    Budzulak J; Majewska KA; Kędzia A
    Endocrine; 2024 Nov; 86(2):782-789. PubMed ID: 39107621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of treatment with recombinant human growth hormone (rhGH) on linear growth and adult height in children with idiopathic short stature (ISS): a systematic review and meta-analysis.
    Paltoglou G; Dimitropoulos I; Kourlaba G; Charmandari E
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1577-1588. PubMed ID: 33035189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope
    Backeljauw P; Miller BS; Levy R; McCormick K; Zouater H; Zabransky M; Campbell K
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):431-440. PubMed ID: 33647196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Human Growth Hormone in Idiopathic Short Stature.
    Tao S; Li G; Wang Q; Hu Y
    Indian J Pediatr; 2015 Jul; 82(7):625-8. PubMed ID: 25893526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Recombinant Human Growth Hormone (rhGH) Therapy in Children with Growth Hormone Deficiency.
    Riaz M; Ibrahim MN; Rai VR; Bibi S; Khoso ZA; Laghari TM
    J Coll Physicians Surg Pak; 2024 Aug; 34(8):932-935. PubMed ID: 39113512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.